Oleg Nodelman Overview
- Firm
- EcoR1 Capital
- Primary Position
-
Founder
- Primary Industry
-
Healthcare
- Active Board Seats
-
10
- Med. Deal Size
-
- Med. Valuation
-
Oleg Nodelman General Information
Biography
Mr. Oleg Nodelmanserves as Non-Executive, Non-Independent Driver at Galapagos he is the Founder of EcoR1 Capital. He served as Portfolio Manager at EcoR1 Capital. He also served as Chief Executive Officer & Chairman at Panacea Acquisition Corp II & Board Member at Nuvation Bio. He serves as a Board Member at Epikast, Scorpion Therapeutics, ReCode Therapeutics, Aktis Oncology, and Paratus Sciences. He also served as Chief Executive Officer and Chairman at Panacea Acquisition. He is a Board Observer of Elevatebio. With 15 years of experience in investing and consulting, he has expertise in all aspects of investment management and deep roots in the biotech and scientific communities. Before founding EcoR1, he was a Portfolio Manager at BVF Partners, one of biotech's first dedicated hedge funds. During his 11 years with BVF, his responsibilities spanned the entire investment process, from opportunity generation and due diligence to portfolio management and trading. He began his career in strategic consulting and organizational management at Mercer Management Consulting (now Oliver Wyman), where he worked with senior management from companies in a variety of industries to develop and implement long-term strategies and build shareholder value. He is active in the biotech community, a member of the President's Council at the Gladstone Institute, and has served on the advisory committee of the Biotech Industry Organization. He serves as a Director at Prothena. He has a Bachelor of Science in Foreign Service with a concentration in Science and Technology from Georgetown University.
Contact Information
Address
- 357 Tehama Street
- Floor 3
- San Francisco, CA 94103
- United States
Oleg Nodelman Positions (1)
Firm name | Firm type | Title | Location | Industry | Since |
---|---|---|---|---|---|
EcoR1 Capital | Investor | Founder | San Francisco, CA | Venture Capital |
Oleg Nodelman Board Seats (11)
Company | Industry | Ownership Status | Financing Status | Location | Since |
---|---|---|---|---|---|
Aktis Oncology | Drug Discovery | Privately Held (backing) | Venture Capital-Backed | Boston, MA | |
AnaptysBio | Biotechnology | Publicly Held | Formerly VC-backed | San Diego, CA | |
ElevateBio | Biotechnology | Privately Held (backing) | Venture Capital-Backed | Waltham, MA | |
Epikast | Media and Information Services (B2B) | Privately Held (backing) | Venture Capital-Backed | New York, NY | |
Galapagos | Media and Information Services (B2B) | Privately Held (backing) | Venture Capital-Backed | Tokyo, Japan |
Oleg Nodelman Lead Partner on Deals (19)
Company | Deal Date | Deal Type | Deal Size | Deal Status | Industry | Location |
---|---|---|---|---|---|---|
Aktis Oncology | 20-Sep-2024 | Early Stage VC (Series B) | Completed | Drug Discovery | Boston, MA | |
AnaptysBio | 13-Aug-2024 | Announced/In Progress | Biotechnology | San Diego, CA | ||
Scorpion Therapeutics | 16-Jul-2024 | Completed | Drug Discovery | Boston, MA | ||
ReCode Therapeutics | 15-Sep-2023 | Completed | Drug Delivery | Menlo Park, CA | ||
Epikast | 28-Feb-2023 | Completed | Media and Information Services (B2B) | New York, NY | ||
Paratus Sciences | 27-Feb-2023 | Completed | Biotechnology | New York, NY | ||
Aktis Oncology | 17-Aug-2022 | Completed | Drug Discovery | Boston, MA | ||
Actio Biosciences | 28-Jul-2022 | Completed | Drug Discovery | San Diego, CA | ||
Nuvation Bio | 10-Feb-2021 | Reverse Merger | Completed | Drug Discovery | New York, NY | |
Nuvation Bio | 10-Feb-2021 | PIPE | Completed | Drug Discovery | New York, NY |
Oleg Nodelman Network (271)
Board Members (118)
Name | Company | Representing | Location | From |
---|---|---|---|---|
Andrew Levin | Aktis Oncology | Self | Boston, MA | |
Dean Mitchell | ReCode Therapeutics | ReCode Therapeutics | Menlo Park, CA | |
Epikast | Epikast | New York, NY | ||
Scorpion Therapeutics | Mass General Brigham Innovation | Boston, MA | ||
Scorpion Therapeutics | Self | Boston, MA |
Portfolio Executives (151)
Name | Company | Role | Deal date | Location |
---|---|---|---|---|
Patrick Baeuerle Ph.D | Aktis Oncology | Co-Founder & Advisor | 20-Sep-2024 | Boston, MA |
Todd Foley | Aktis Oncology | Co-Founder & Chairman | 20-Sep-2024 | Boston, MA |
Aktis Oncology | Advisor, Scientific Advisory Board | 20-Sep-2024 | Boston, MA | |
Aktis Oncology | Chief Executive Officer, President & Board Member | 20-Sep-2024 | Boston, MA | |
Aktis Oncology | Chief Scientific Officer | 20-Sep-2024 | Boston, MA |
Fund Team Members (2)
Name | Investor | Fund | Fund Location |
---|---|---|---|
EcoR1 Capital | San Francisco, CA | ||
EcoR1 Capital | San Francisco, CA |
Oleg Nodelman Affiliated Funds (2)
Fund | Investor | Fund Type | Status | Vintage | Size | Dry Powder | IRR | IRR Quartile |
---|---|---|---|---|---|---|---|---|
EcoR1 Venture Opportunity Fund | EcoR1 Capital | Venture - General | Closed | 2019 | ||||
EcoR1 Capital Fund | EcoR1 Capital | Hedge Fund | Open |
Oleg Nodelman FAQs
-
Who is Oleg Nodelman?
Mr. Oleg Nodelmanserves as Non-Executive, Non-Independent Driver at Galapagos he is the Founder of EcoR1 Capital.
-
How much does Oleg Nodelman typically invest?
Oleg Nodelman's median deal size is
. -
What is Oleg Nodelman’s main position?
Oleg Nodelman’s primary position is Founder.
-
What are the contact details for Oleg Nodelman?
Oleg Nodelman’s email address is ol
and his phone number is +1 (415) . -
How many active board seats does Oleg Nodelman hold?
Oleg Nodelman holds 11 board seats including Aktis Oncology, AnaptysBio, ElevateBio, Epikast, and Galapagos.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »